High-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements represent a quite recently defined entity of lymphoma with aggressive nature, high genomic complexity and poor prognosis [9]. The gene discussed is BCL6; the disease is B-cell non-Hodgkin lymphoma.